TG Therapeutics Stock Surges After Drug Trial Update - TG Therapeutics (NASDAQ:TGTX)

Shares of TG Therapeutics Inc (NASDAQ: TGTX) are climbing Wednesday after early-stage clinical trial data for new BRIUMVI MS formulation.

Raccontata dabenzinga.com